Evidence map›Paper›PMID 41509068›Full record

ArticleToxicology reports2026

Synthesis, characterization, and anticancer evaluation of

Zakariae Abbaoui, Oussama Khibech, Hüseyin Karci, Muhammed Dündar, İlknur Özdemir, Nevin Gürbüz, Ahmet Koç, Wilson Agerico Dino, İsmail Özdemir, Naifa Alenazi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Heterocycles in Medicinal Chemistry III.Molecules (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zakariae AbbaouiUniversity Mohammed Premier, Faculty of sciences, Department of Chemistry, Laboratory of Applied and Environmental Chemistry (LCAE), Oujda 60000, Morocco.
Oussama KhibechUniversity Mohammed Premier, Faculty of sciences, Department of Chemistry, Laboratory of Applied and Environmental Chemistry (LCAE), Oujda 60000, Morocco.
Hüseyin KarciInonu University, Faculty of Arts and Sciences, Department of Chemistry, Malatya 44280, Turkey.
Muhammed DündarInonu University, Faculty of Arts and Sciences, Department of Molecular Biology and Genetics, Malatya 44280, Turkey.
İlknur ÖzdemirInonu University, Faculty of Arts and Sciences, Department of Chemistry, Malatya 44280, Turkey.
Nevin GürbüzInonu University, Faculty of Arts and Sciences, Department of Chemistry, Malatya 44280, Turkey.
Ahmet Koçİnönü University Drug Administration and Research Center, Malatya 44280, Turkey.
Wilson Agerico DinoOsaka University, Department of Applied Physics, Suita, Osaka 565-0871, Japan.
İsmail ÖzdemirInonu University, Faculty of Arts and Sciences, Department of Chemistry, Malatya 44280, Turkey.
Naifa AlenaziDepartment of Pharmaceutical Science, College of Pharmacy, Princess Nourah bint Abdulrahman University, PO Box 84428, Riyadh 11671, Saudi Arabia.
Rachid TouzaniUniversity Mohammed Premier, Faculty of sciences, Department of Chemistry, Laboratory of Applied and Environmental Chemistry (LCAE), Oujda 60000, Morocco.
Hanan AlghibiwiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to synthesize a novel series of

Indexed as

ADME profilingAnticancer activityDrug designIn silico studyN-heterocycles

Identifiers

PMID41509068
PMCPMC12775995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.